Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic acid versus tenofovir switch for low bone mineral density in adults with HIV
2013-003359-39Phase 4Completed
- Sponsor
- Fundació Clínic per a la Recerca Biomèdica
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in human immunodeficiency virus infection (HIV) and low bone mineral density comparing Zoledronic acid arm with Tenofovir switch arm (2 arms). Primary endpoint: Mean percent change in lumbar spine bone mineral density at 2 years. Started Jan 2014; status: completed.
02
Drugs
zoledronic acidtenofovir
03
Conditions
human immunodeficiency virus infection (HIV)low bone mineral density
Beyond the preview
Go deeper on 2013-003359-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003359-39.